Dataset from A Phase 3 Double-blind Study to Evaluate the Efficacy and Safety of Dexlansoprazole (30 mg QD) Compared to Placebo on Heartburn Relief in Subjects With Symptomatic Nonerosive Gastroesophageal Reflux Disease (GERD)
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/00007406
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine the efficacy and safety of dexlansoprazole compared
to placebo in relief of daytime and nighttime heartburn over 4 weeks in Chinese participants
with symptomatic non-erosive Gastroesophageal Reflux Disease (GERD).
创建时间：
2025-10-01
